SCHEMBL3218704

SCHEMBL3218704

O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1ccc2c(c1)OCO2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.67
▸ APP P05067 1/20 0.67
▸ MAOB P27338 3/20 0.63
▸ AKR1B10 O60218 1/20 0.63
▸ AKR1B1 P15121 1/20 0.63
▸ PTGS2 P35354 1/20 0.63
▸ GLO1 Q04760 1/20 0.63
▸ CAMK2A Q9UQM7 1/20 0.63
▸ KDM4E B2RXH2 1/20 0.62
▸ ALDH1A1 P00352 1/20 0.62
▸ BACE1 P56817 4/20 0.59
▸ HDAC6 Q9UBN7 2/20 0.59
▸ NPC1 O15118 1/20 0.59
▸ RAB9A P51151 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ TRPM8 Q7Z2W7 1/20 0.58
▸ CYP1A2 P05177 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.56
▸ HDAC3 O15379 1/20 0.55
▸ HDAC1 Q13547 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3218729 1.00 MAPT (0.67) MAPTAPPMAOBAKR1B10AKR1B1
SCHEMBL17691541 0.93 MAPT (0.71) MAPTAPPMAOBKDM4EALDH1A1
SCHEMBL3210767 0.91 MAPT (0.71) MAPTAPPMAOBAKR1B10AKR1B1
SCHEMBL3210786 0.91 MAPT (0.71) MAPTAPPMAOBAKR1B10AKR1B1
SCHEMBL16576815 0.85 TRPM8 (0.68) MAPTAPPMAOBKDM4EALDH1A1
SCHEMBL21933269 0.85 CYP19A1 (0.69) MAPTMAOBKDM4EALDH1A1HDAC6
SCHEMBL3209559 0.83 KDM4E (0.73) MAPTAPPKDM4EALDH1A1NPC1
SCHEMBL3209529 0.83 KDM4E (0.73) MAPTAPPKDM4EALDH1A1NPC1
SCHEMBL25209543 0.83 MAPT (0.84) MAPTMAOBKDM4EALDH1A1NPC1
SCHEMBL3440510 0.83 MAPT (0.84) MAPTMAOBKDM4EALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 — — US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 — — US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 MAPT 8/4885APP 2/4885MAOB 969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback